12
Participants
Start Date
August 13, 2021
Primary Completion Date
February 24, 2022
Study Completion Date
February 24, 2022
IN-A002(IN-115314) capsule
Oral Administration of IN-A002(IN-115314), single dose
IN-A002(IN-115314) capsule
Oral Administration of IN-A002(IN-115314), single dose
RECRUITING
Seoul National University Hospital, Dept. of Clinical Pharmacology, Seoul
Lead Sponsor
HK inno.N Corporation
INDUSTRY